logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

美国借贷中心率先援助大量物资,抗击武汉冠状病毒

EB-5 Industry Leader ALC Spearheads Medical Donations and Support to Help Fight Wuhan Coronavirus

Feb 6, 2020

Life Science

中国冠状病毒最新播报:继续传播,已有婴儿感染

China Coronavirus Update: Continued Spread, Run on Antivirals and Facemasks, Baby Diagnosed

Feb 6, 2020

Life Science

中山康方生物 上市

AkesoBio Files for $300 Million Hong Kong IPO to Develop Antibody Portfolio

Feb 6, 2020

Life Science

华为、阿里巴巴部署人工智能,快速发现冠状病毒

Huawei, Alibaba Deploy AI to Quickly Spot Coronavirus Cases, Useful Drugs

Feb 6, 2020

Life Science, Technology

比尔和梅琳达·盖茨基金会出资,助力抗击新型冠状病毒

Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response

Feb 5, 2020

Life Science

中国武汉病毒所申请抗冠状病毒“神药”瑞得西韦的专利,是否抢注成热议

China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus

Feb 5, 2020

Life Science

DIAGNOS Announces Private Placement of Common Shares

Feb 5, 2020

Life Science

医疗保健精选——FDA批准BioXcel新药临床试验,葛兰素史克分拆消费业务

Healthcare Roundup – FDA signs off on BioXcel IND, Glaxo to spin out consumer business

Feb 5, 2020

Life Science

中国贝达药业向EyePoint授予新型眼科药物授权

China’s Betta Pharma Sells EyePoint Sole Rights to Develop Ophthalmic Drugs Overseas

Feb 4, 2020

Life Science

耐克叫苦,冠状病毒影响中国业务

Nike says the coronavirus epidemic will have ‘material impact’ on China operations

Feb 4, 2020

Consumer Goods, Technology

冠状病毒爆发对中国保险公司的影响将是“有限的”和“可控制的”

Impact of coronavirus outbreak on China insurers will be ‘limited’ and ‘manageable,’ analysts say

Feb 4, 2020

Life Science

百奥泰

Bio-Thera Solutions Announces Positive Top-Line Results for BAT1706, A Proposed Biosimilar to Avastin®

Feb 4, 2020

Life Science

Gilead Starts China Phase III Trial of Remdesivir in Coronavirus Patients

Feb 4, 2020

Life Science

医疗保健精选——百时美施贵宝和BioMotiv成立新药合资企业,百特获得内毒素过滤器的许可授权

Healthcare Roundup – Bristol-Myers and BioMotiv launch new drug venture, Baxter in-licenses rights to endotoxin filter

Feb 4, 2020

Life Science

Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the “Cellular Therapy in the Asia Pacific Region” Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) — ASTCT and CIBMTR Tandem Meeting 2020

Feb 4, 2020

Life Science

AntiCancer Inc.口服重组蛋氨酸酶有望杀死2019-nCoV冠状病毒

AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV Coronavirus

Feb 3, 2020

Technology

Eurofins Discovery和上海泓博智源医药宣布商业合作

Eurofins Discovery and PharmaResources Announce Commercial Cooperation

Feb 3, 2020

Life Science

对冲基金巨头Citadel向冠状病毒救助捐资750万美元

Citadel Mobilizes $7.5 Million to Support Coronavirus Relief Efforts in China and the United States

Feb 3, 2020

Life Science

  • ‹‹ Previous
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada